# A Training Set for the HRD Model in EOC

> **NCT04651933** · — · UNKNOWN · sponsor: **Lei Li** · enrollment: 200 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer
- BRCA Mutation
- Loss of Heterozygosity
- Prognosis
- Platinum Resistance
- Homologous Recombination Deficiency

## Interventions

- **GENETIC:** Homologous recombination deficiency model

## Key facts

- **NCT ID:** NCT04651933
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-26
- **Primary completion:** 2022-11-26
- **Final completion:** 2022-11-26
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04651933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04651933, "A Training Set for the HRD Model in EOC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04651933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*